Biopharmaceutical Analysis & Statistics, January 2014 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

571-600 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Genexine Co., Ltd. (095700) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genexine Co., Ltd. (095700) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Genexine, Inc. (Genexine) is a research and development company, based in Korea. The company develops therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
BioArctic Neuroscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioArctic Neuroscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary BioArctic Neuroscience AB (BioArctic) is a biotechnology company. It develops and offers treatments for patients with disorders in the central nervous system. The company's product portfolio includes ...

  • Industries : Biopharmaceutical
Global Trends and Developments in Enzymes

Global Trends and Developments in Enzymes

  • $ 1 995
  • Industry report
  • January 2014
  • by Euromonitor International

Enzymes are used across a wide range of consumer products, and, as companies invest in R&D, more uses are being found. Helping manufacturers to cut costs and using enzymes to reduce a product's environmental ...

  • Industries : Biopharmaceutical
  • Countries : World
Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis

Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis

  • $ 2 838
  • Industry report
  • January 2014
  • by La Merie Publishing

Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis The report entitled "Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis" published in January 2014 ...

  • Industries : Biopharmaceutical
Immunomedics, Inc. (IMMU) - Financial and Strategic SWOT Analysis Review

Immunomedics, Inc. (IMMU) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Immunomedics, Inc. (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

  • $ 2 500
  • Industry report
  • January 2014
  • by MP Advisors

Positive sentiments for the biotech sector have prevailed in the last two to three years, and we expect this trend to continue for the next year too. Our optimism is based on the continuity in the flow ...

  • Industries : Biopharmaceutical
  • Countries : World
Analysis of the Global Biosimilars Market

Analysis of the Global Biosimilars Market

  • $ 10 000
  • Industry report
  • January 2014
  • by Frost & Sullivan

Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Europe, China, South Korea, South America, Japan, Australia, Germany, India, Asia, Spain, Italy, France, United Kingdom, North America, Argentina, Brazil, Mexico
World Enzymes Market

World Enzymes Market

  • $ 6 300
  • Industry report
  • January 2014
  • by Freedonia

World demand to increase 6.4% annually through 2017 World enzyme demand is forecast to rise 6.4 percent per annum to $6.9 billion in 2017. Increasing per capita incomes in developing countries will help ...

  • Industries : Biopharmaceutical
  • Countries : World
Global And China Specialty Enzymes Industry 2014 Market Research Report

Global And China Specialty Enzymes Industry 2014 Market Research Report

  • $ 2 200
  • Industry report
  • January 2014
  • by QY Research Group

Description The report firstly introduced Specialty Enzymes basic information included Specialty Enzymes definition classification application industry chain structure industry overview; international ...

  • Industries : Biopharmaceutical
  • Countries : China
Global Biobetters Trends Industry

Global Biobetters Trends Industry

  • $ 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

The report analyzes and presents an overview of Biobetters market worldwide. "Biobetters or Biosuperiors are novel molecules derived from successful, approved biologic products that have been customized ...

  • Industries : Biopharmaceutical
  • Countries : United States, World, South Korea, Switzerland, Netherlands, Germany, Europe, United Kingdom, Russian Federation, France, Taiwan, Israel, India, China, Asia, North America
Global Virus-Like Particles (VLPs) Trends Industry

Global Virus-Like Particles (VLPs) Trends Industry

  • $ 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

The report analyzes and presents an overview of Virus-Like Particles (VLPs) market worldwide. "Virus-like particles or VLPs bear high structural resemblance to viruses, though completely non-infectious ...

  • Industries : Biopharmaceutical
  • Countries : World, Switzerland
Zenotech Laboratories Limited - Product Pipeline Review - 2013

Zenotech Laboratories Limited - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • December 2013
  • by Global Markets Direct

Zenotech Laboratories Limited - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Zenotech Laboratories Limited - Product Pipeline Review - 2013” provides data ...

  • Industries : Biopharmaceutical
  • Countries : World
Body Organ Biomedical Corp. (4177) - Product Pipeline Analysis, 2013 Update

Body Organ Biomedical Corp. (4177) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

Summary Body Organ Biomedical Corp. (BOBC) is a regenerative solution provider. The company offers services for orthopedics, ophthalmology, dentistry, plastic and other surgery. Its products include ologen ...

  • Industries : Biopharmaceutical
  • Countries : Taiwan
Global Protein Ingredient Market 2014-2018

Global Protein Ingredient Market 2014-2018

  • $ 2 500
  • Industry report
  • December 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Protein Ingredient market to grow at a CAGR of 6.03 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing ...

  • Industries : Biopharmaceutical
  • Countries : World
Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013

Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013

  • $ 1 898
  • Industry report
  • December 2013
  • by Espicom Business Intelligence

The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition. The major players include ...

  • Industries : Biopharmaceutical
  • Countries : United States, World, Europe, India
Global And China Methanol Protein Industry 2013 Market Research Report

Global And China Methanol Protein Industry 2013 Market Research Report

  • $ 2 200
  • Industry report
  • December 2013
  • by QY Research Group

Description The report firstly introduced Methanol Protein basic information included Methanol Protein definition classification application industry chain structure industry overview; international market ...

  • Industries : Biopharmaceutical
  • Countries : China
Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018

  • $ 4 650
  • Industry report
  • November 2013
  • by MarketsandMarkets

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application ...

  • Industries : Biopharmaceutical
  • Countries : World
Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis Review

Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...

  • Industries : Biopharmaceutical
Tianjin TEDA Biomedical Co., Ltd. (8189) - Financial and Strategic SWOT Analysis Review

Tianjin TEDA Biomedical Co., Ltd. (8189) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Tianjin TEDA Biomedical Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biopharmaceutical
Auricle Biomedical Corporation (AUB.P) - Strategic SWOT Analysis Review

Auricle Biomedical Corporation (AUB.P) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Auricle Biomedical Corporation provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...

  • Industries : Biopharmaceutical
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

  • $ 2 495
  • Industry report
  • November 2013
  • by CHI Insight Pharma Reports

This report covers several technologies, epigenetic targets, and market outlook. The first part of this report covers necessary background information, mostly pertaining to epigenetic targets, and the ...

  • Industries : Biopharmaceutical
Commercialisation of Biosimilars: strategies for market penetration

Commercialisation of Biosimilars: strategies for market penetration

  • $ 495
  • Industry report
  • November 2013
  • by Firstword Pharma

Introduction Times, they are a-changin'—at least for the American biological product market. With five major biological products worth a collective US$35 billion in annual sales now facing imminent patent ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global And China Industrial Enzyme Industry 2013 Market Research Report

Global And China Industrial Enzyme Industry 2013 Market Research Report

  • $ 2 200
  • Industry report
  • November 2013
  • by QY Research Group

Description The report firstly introduced Industrial Enzyme basic information included Industrial Enzyme definition classification application industry chain structure industry overview; international ...

  • Industries : Biopharmaceutical
  • Countries : China
Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

  • $ 3 500
  • Industry report
  • October 2013
  • by GBI Research

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth Summary GBI Research has released the pharmaceutical report “Monoclonal ...

  • Industries : Biopharmaceutical
  • Countries : World
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

  • $ 1 914
  • Industry report
  • October 2013
  • by La Merie Publishing

A comparative analysis and assessment of TCR technologies, pipelines and companies from an industry perspective Therapeutic monoclonal antibodies have become an increasingly successful treatment modality ...

  • Industries : Biopharmaceutical
  • Countries : United States
Therapy Class Overview: Rituximab biosimilar

Therapy Class Overview: Rituximab biosimilar

  • $ 2 000
  • Industry report
  • October 2013
  • by MP Advisors

Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson's Remicade, which ...

  • Industries : Biopharmaceutical
  • Countries : Mexico, India, World, United States, Europe
Market Access Collection - Report Bundle

Market Access Collection - Report Bundle

  • $ 4 095
  • Industry report
  • October 2013
  • by Firstword Pharma

Market Access Collection - Report Bundle consists of all 4 reports from our Market Access Report Series. Reports Included 1. Market Access Canada (September 2013) 2. Market Access in the EU5 - a comparative ...

  • Industries : Biopharmaceutical
Emerging Markets Collection - Report Bundle

Emerging Markets Collection - Report Bundle

  • $ 3 295
  • Industry report
  • October 2013
  • by Firstword Pharma

Emerging Markets Collection - Report Bundle consists of all 4 reports from our Emerging Market Report Series. Reports Included 1. Inside China's Pharma Sales Force - insights from the frontline (July 2013) ...

  • Industries : Biopharmaceutical
  • Countries : China
Global Markets and Manufacturing Technologies for Protein Drugs

Global Markets and Manufacturing Technologies for Protein Drugs

  • $ 6 650
  • Industry report
  • October 2013
  • by BCC Research

STUDY OBJECTIVES The objective of BCC in conducting this study is to provide an overview of the current and future characteristics of the global market for protein drugs/therapeutics. The key objective ...

  • Industries : Biopharmaceutical
  • Countries : World
Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Peptide Hormones and Therapeutic Enzymes

Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Peptide Hormones and Therapeutic Enzymes

  • $ 5 370
  • Industry report
  • October 2013
  • by BCC Research

STUDY OBJECTIVES The objective of BCC in conducting this study is to provide an overview of the current and future characteristics of the global market for protein drugs/therapeutics. The key objective ...

  • Industries : Biopharmaceutical
  • Countries : World

21 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.